MI Profile™ Reports
New biomarker discoveries are being made every day, and Caris Molecular Intelligence makes it possible to apply the latest data to real-world cancer treatment.
Clinically Actionable Reports
- Each MI Profile report contains biomarker expression levels, drugs associated with response and lack of response, and potential clinical trials opportunities.
- Comprehensive report identifies both On- and Off-Compendium drug associations, plus the Clinical Trials Connector™.
- Select report identifies only On-Compendium drug associations, plus the Clinical Trials Connector. The results of all biomarkers not associated with On-Compendium therapies will be listed in the appendix section of the report.
- Next-Generation Sequencing Panel can be added to any Comprehensive or Select report and enables an even more in-depth biomarker analysis by investigating up to 44 additional genes. Or the Next-Generation Sequencing Panel can be ordered as a standalone service.